Project Grant RF1NS126609

Award Date 8/15/22
Completion Date 7/31/25
Dollars Obligated $4.7M
Funding Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Minnesota, USA
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $4,390,219 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the Regents of the University of Minnesota, Office of Sponsored Projects Administration. The 3-year project aims to determine the prognostic importance of atrial myopathy for incident dementia in the oldest-old population, relate atrial myopathy progression to cognitive decline and...
This three-year, $6.5 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, will fund research under the Aging Research program (CFDA 93.866). The grantee, the Regents of the University of Minnesota, will assess the acute and long-term impacts of SARS-CoV-2 infection on cognitive function and neuropathology in aging and Alzheimer's disease. Specifically, the University of Minnesota researchers will test hypotheses about how the...
This Project Grant award of $2,156,000.00 from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) supports a research project to develop and validate non-invasive neuroimaging methods for quantifying brain oxygen availability, pH, and carbon dioxide levels. The goal is to better understand the relationship between cerebral blood flow, neuronal metabolic demands, and the regulation of waste products, in order to identify the underlying causes of brain...
The National Institute on Aging (NIA) awarded a $2,501,096 Project Grant (CFDA 93.866 - Aging Research) to the Regents of the University of Minnesota's Office of Sponsored Projects Administration on August 15, 2024. This grant, titled "Establishing Mechanisms of Benefit to Reinforce the Alzheimer's Care Experience AD/ADRD Roybal Center: EMBRACE", aims to provide scientific infrastructure to support the testing of mechanisms in tailored home and community dementia care intervention...
This $1,919,387 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to assess the impact of reduced cerebral blood flow and neurovascular coupling on brain function and homeostasis in aging. The project aims to use a novel computational homeostatic modeling (HOMOD) approach to calculate regional brain tissue and capillary blood levels of CO2, O2, and pH in young and elderly subjects. The research will utilize calibrated fMRI and fMRS...
The National Institute on Aging (NIA) awarded a $780,466 Project Grant (CFDA 93.866 Aging Research) to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, with a period of performance from December 15, 2024 to November 30, 2029. The goal of this project is to develop digital biomarkers using single-channel sleep electroencephalography (EEG) to monitor brain health and detect pathological aging and early neurodegenerative changes, such as those seen...
The Regents of the University of Minnesota received a $599,994.30 Project Grant award from the National Institutes of Health National Institute of Biomedical Imaging and Bioengineering to develop novel radiofrequency hardware for use at 10.5 Tesla to obtain functional magnetic resonance imaging signals at ultra-high resolutions in non-human primates. The goal is to directly test how well whole brain directional connectivity estimates from fMRI correspond with ground truth tract tracing...
The University of Minnesota was awarded a $3,972,414 Project Grant from the National Institute of Neurological Disorders and Stroke within the Department of Health and Human Services to develop an electro-optical multiphoton microscope. The microscope will leverage advances in electro-optical beam deflection to enable random-access multiphoton interrogation of neurons and synapses with sub-microsecond access times. This will allow neuroscientists to collect the simultaneous recordings needed...
This $4.46 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, supports research under the Aging Research program (CFDA 93.866) to develop a new in vivo magnetic resonance imaging biomarker for early detection of Alzheimer's disease neurodegeneration. Specifically, the awardee, Washington University, will utilize quantitative gradient recalled echo MRI techniques to identify two types of hippocampal tissue in preclinical and mild...
The National Institute on Aging (NIA), part of the Department of Health and Human Services National Institutes of Health, awarded a $3.37 million Project Grant to The University of Texas at Arlington to develop an individualized deep connectome framework for Alzheimer's disease and related dementias (ADRD) analysis. The three-year grant, awarded on August 18, 2022 under the NIA's Aging Research program (CFDA 93.866), will support research to discover and identify individualized...

The Regents of the University of Minnesota will receive $4.67 million under a three-year Project Grant from the National Institute on Aging within the Department of Health and Human Services. The grant funds research under the Aging Research program (CFDA 93.866) to characterize neuroplastic changes and their relationship to emerging motor and cognitive deficits in individuals with isolated rapid eye movement sleep behavior disorder (IRBD).

Over the period of performance from August 2022 through July 2025, the University will utilize ultra-high field 7 Tesla magnetic resonance imaging and paired associative stimulation techniques to examine structural and functional connectivity and cortical plasticity in prefrontal and sensorimotor pathways of IRBD patients. Researchers will assess progression over two years and relationships to measures of motor and cognitive function. Insights aim to further understanding of temporal evolution of neuroplastic changes during prodromal disease states and factors influencing manifestation of motor and cognitive signs in individuals at high risk of developing Parkinson's disease, dementia with Lewy bodies, or related synucleinopathies.

Generated 1/6/24, 2:26 PM